HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paul K Witting Selected Research

Myoglobinuria

5/2011Comparing the potential renal protective activity of desferrioxamine B and the novel chelator desferrioxamine B-N-(3-hydroxyadamant-1-yl)carboxamide in a cell model of myoglobinuria.
8/2010The synthetic polyphenol tert-butyl-bisphenol inhibits myoglobin-induced dysfunction in cultured kidney epithelial cells.
1/2008Myoglobin induces oxidative stress and decreases endocytosis and monolayer permissiveness in cultured kidney epithelial cells without affecting viability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Paul K Witting Research Topics

Disease

20Inflammation (Inflammations)
01/2022 - 04/2005
17Neoplasms (Cancer)
10/2021 - 07/2005
12Atherosclerosis
11/2021 - 08/2002
6Hypoxia (Hypoxemia)
01/2019 - 04/2006
6Acute Kidney Injury (Acute Renal Failure)
12/2018 - 05/2011
6Necrosis
08/2014 - 01/2008
5Myocardial Infarction
10/2020 - 11/2006
5Rhabdomyolysis
12/2018 - 08/2010
5Ischemia
07/2017 - 07/2006
4Disease Progression
06/2022 - 10/2009
4Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 04/2006
4Infarction (Infarctions)
01/2022 - 07/2013
4Lung Neoplasms (Lung Cancer)
12/2014 - 11/2011
4Burns
09/2011 - 01/2008
3Hypertension (High Blood Pressure)
07/2022 - 11/2012
3Neuroblastoma
01/2022 - 09/2005
3Myoglobinuria
05/2011 - 01/2008
2Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2017
2Breast Neoplasms (Breast Cancer)
10/2021 - 01/2005
2Colitis
01/2020 - 01/2020
2Infections
01/2017 - 03/2010
2Stroke (Strokes)
09/2014 - 04/2006
2Myocardial Ischemia (Ischemic Heart Diseases)
07/2013 - 09/2006
2Proteinuria
03/2013 - 09/2011
2Cognitive Dysfunction
01/2013 - 10/2009
2Atherosclerotic Plaque (Atheroma)
10/2011 - 10/2006
2Prostatic Neoplasms (Prostate Cancer)
07/2010 - 10/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2009 - 02/2009
2Acute Coronary Syndrome
02/2009 - 01/2009
2Thrombosis (Thrombus)
01/2009 - 11/2006
2Vascular Diseases (Vascular Disease)
04/2006 - 09/2004
1Fibrosis (Cirrhosis)
11/2021

Drug/Important Bio-Agent (IBA)

13AntioxidantsIBA
06/2022 - 08/2002
10Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2021 - 01/2009
9Proteins (Proteins, Gene)FDA Link
07/2022 - 01/2005
9Oxidants (Oxidizing Agents)IBA
04/2021 - 04/2005
7Reactive Oxygen Species (Oxygen Radicals)IBA
04/2021 - 04/2006
7Vitamin EFDA LinkGeneric
09/2011 - 01/2005
6LipidsIBA
12/2018 - 08/2003
5Peroxidase (Myeloperoxidase)IBA
01/2022 - 04/2005
5Adenosine Triphosphate (ATP)IBA
02/2019 - 04/2006
5Thromboplastin (Tissue Factor)IBA
12/2018 - 02/2009
5MyoglobinIBA
12/2016 - 01/2008
5Succinic Acid (Succinate)IBA
12/2013 - 07/2005
4Hypochlorous Acid (Hypochlorite)IBA
10/2020 - 04/2005
4CytokinesIBA
02/2020 - 05/2009
4Transcription Factors (Transcription Factor)IBA
01/2020 - 07/2013
4Selenious Acid (Selenite)IBA
05/2019 - 11/2011
4Superoxides (Superoxide)IBA
05/2019 - 08/2010
4Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2018 - 01/2009
4Glucose (Dextrose)FDA LinkGeneric
09/2014 - 07/2006
4SeleniumIBA
09/2014 - 11/2011
4Biomarkers (Surrogate Marker)IBA
08/2014 - 09/2008
3nitroxylIBA
01/2022 - 01/2020
3Apolipoproteins E (ApoE)IBA
11/2021 - 08/2003
3ApolipoproteinsIBA
01/2021 - 08/2003
3Messenger RNA (mRNA)IBA
01/2021 - 11/2012
3Pharmaceutical PreparationsIBA
10/2020 - 07/2005
3Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2020 - 05/2011
3Drinking WaterIBA
01/2020 - 11/2012
3AnionsIBA
05/2019 - 08/2014
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
12/2018 - 05/2012
3PolyphenolsIBA
12/2018 - 07/2008
3Deferoxamine (Desferal)FDA LinkGeneric
01/2017 - 02/2010
3CholesterolIBA
06/2015 - 08/2002
3Biological ProductsIBA
05/2013 - 10/2009
3alpha-TocopherolFDA Link
06/2011 - 08/2002
3Probucol (Lorelco)FDA Link
04/2006 - 08/2002
2Peptides (Polypeptides)IBA
07/2022 - 10/2009
2tempolIBA
01/2022 - 11/2012
2Sulfhydryl Compounds (Thiols)IBA
01/2022 - 09/2014
2ChemokinesIBA
02/2020 - 05/2009
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2020 - 01/2020
2Dextrans (Dextran)FDA Link
01/2020 - 01/2020
2EnzymesIBA
01/2019 - 07/2010
2salicylhydroxamic acid (SHAM)IBA
12/2016 - 06/2015
2Interleukin-6 (Interleukin 6)IBA
05/2015 - 12/2009
2Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
08/2014 - 09/2006
2Heme Oxygenase-1IBA
11/2012 - 04/2006
2Chelating AgentsIBA
05/2011 - 02/2010
2EicosanoidsIBA
07/2010 - 10/2009
2Arachidonic Acid (Vitamin F)IBA
07/2010 - 10/2009
2NeuroglobinIBA
07/2008 - 04/2006
2Glutathione (Reduced Glutathione)IBA
07/2008 - 06/2006
2Oxygen (Dioxygen)IBA
07/2008 - 04/2006
2Adenosine Diphosphate (ADP)IBA
07/2006 - 04/2006
2Lipoproteins (Lipoprotein)IBA
08/2003 - 08/2002
11,10- phenanthroline- platinum(II)- ethylenediamine (PEPT)IBA
07/2022
1Oxidopamine (6 Hydroxydopamine)IBA
01/2022
1NeurotoxinsIBA
01/2022
1HDL CholesterolIBA
01/2022
1CollagenIBA
11/2021
1p38 Mitogen-Activated Protein KinasesIBA
11/2021
1Matrix Metalloproteinases (MMPs)IBA
11/2021
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
11/2021
1AcidsIBA
10/2021
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2021
1Fatty Acids (Saturated Fatty Acids)IBA
10/2021
1Epoxy Compounds (Epoxides)IBA
10/2021

Therapy/Procedure

6Therapeutics
10/2020 - 09/2005